HomeTransMedics Inc.

TransMedics Inc.

TransMedics, Inc. Receives FDA Pre-Market Approval for its OCS™ Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation

4/12/18: "This is a major milestone for TransMedics and the field of thoracic transplantation," said Dr. Waleed Hassanein, CEO of TransMedics.